Triple attack on pancreatic cancer before surgery aims to extend lives
NCT ID NCT06384560
Summary
This study is testing a new three-part treatment for patients with pancreatic cancer that can be surgically removed. Before surgery, patients receive a combination of chemotherapy, immunotherapy, and targeted radiation. The goal is to see if this intensive approach helps control the cancer better and helps patients live longer without the disease progressing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam University Medical Center
RECRUITINGAmsterdam, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Erasmus University Medical Center
RECRUITINGRotterdam, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Maastricht University Medical Center
NOT_YET_RECRUITINGMaastricht, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Antonius Ziekenhuis
RECRUITINGNieuwegein, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.